Literature DB >> 19716317

Testing genotoxicity and cytotoxicity strategies for the evaluation of commercial radiosterilized fetal calf sera.

Juan Pablo Pilili1, Norma V González, Gabriela Molinari, Miguel A Reigosa, Sonia Soloneski, Marcelo L Larramendy.   

Abstract

Effects of 18 commercial lots of fetal calf serum (FCS) after gamma-irradiation and their non-irradiated counterparts were comparatively analyzed on CHO-K1 and MDBK MDL1 cells for genotoxicity [sister chromatid exchange (SCE), micronuclei (MNi), and single cell gel electrophoresis (SCGE)], cytotoxicity [cell-cycle progression (CCP), proliferative replication index (PRI), mitotic index (MI), growth promotion (GP), and plating efficiency (PE)], and microbiological properties (mycoplasma and bovine viral diarrhea virus contamination). SCE and SCGE were the most informative end-points for genotoxicity since significant differences were found in 44.4% (P<0.05-0.001, Student's t-test) and 61.1% (P<0.05-0.001, chi(2) test) samples, respectively. MI was the cytotoxicity assay revealing the greatest variation, showing differences in 66.7% (P<0.05-0.001, chi(2) test) samples. Thus, these three end-points for screening bioproducts such as FCS were found most suitable for detecting potential geno-cytotoxicants in biological samples; their simultaneous use could be strongly recommended. Copyright 2009 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716317     DOI: 10.1016/j.biologicals.2009.08.014

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  1 in total

1.  Effects of gender-specific adult bovine serum on myogenic satellite cell proliferation, differentiation and lipid accumulation.

Authors:  Dong-Mok Lee; Prati Bajracharya; Eun Ju Lee; Ji-Eun Kim; Hyung-Jeong Lee; Taehoon Chun; Jiehoe Kim; Kyung Hyun Cho; Jongsoo Chang; Seongkoo Hong; Inho Choi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-05-26       Impact factor: 2.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.